ProCE Banner Activity

My Thoughts on the Implications of Key New Data in B-Cell Malignancies From ASCO and EHA 2020

Clinical Thought
Are you aware of the latest practice changing new data related to the care of patients with B-cell malignancies from ASCO and EHA 2020?

Released: July 16, 2020

Expiration: July 15, 2021

No longer available for credit.

Share

Faculty

Lydia Scarfò

Lydia Scarfò, MD

Assistant Professor
Internal Medicine
Università Vita-Salute San Raffaele
Consultant Hematologist
Strategic Research Program on CLL
Milan, Italy

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Lydia Scarfò, MD

Assistant Professor
Internal Medicine
Università Vita-Salute San Raffaele
Consultant Hematologist
Strategic Research Program on CLL
Milan, Italy

Lydia Scarfò, MD, has disclosed that she has received consulting fees from AbbVie, AstraZeneca, Gilead Sciences, and Janssen.